HistoRx
New Haven
About HistoRx
HistoRx is developing theranostic solutions to towards individualized patient care. HistoRx's proprietary technology delivers objective and reproducible multiparametric analysis of proteins in tissue, providing insights into cancer treatment.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Total funding: $15.3M
- Funding stage: M&A
- Last round: Series Unknown (May 2011)
- Website: historx.com
- Phone: 12034987501
Industries & Categories
Alternative Medicine, Biotechnology, Precision Medicine, Therapeutics
Canonical: https://fsome.com/organization/historx-2442047 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.